Physician profile
Sandhya B Iyer
NPI 1285708073
$2,044.16
in general payments reported to CMS, 2019-2025
19 companies · $465 in 2025
The $465 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $221 · 2021: $271 · 2022: $224 · 2023: $65.99 · 2024: $486 · 2025: $465.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,016.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $243.35 | 2019-2025 | |
| Tarsus Pharmaceuticals, INC. | $224.09 | 2024-2025 | Xdemvy |
| Amgen INC. | $216.93 | 2025 | Tepezza |
| Alcon Vision LLC | $206.96 | 2019-2024 | Dailies Total1, Clareon |
| Bausch & Lomb Americas INC. | $161.85 | 2023-2024 | Miebo, Xiidra |
| Coopervision INC. | $131.12 | 2022-2024 | Misight Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $118.25 | 2021 | |
| Dompe US, INC. | $114.32 | 2019 | |
| Horizon Therapeutics Plc | $113.01 | 2022 | |
| Covidien LP | $112.00 | 2019 | |
| Glaukos Corporation | $104.30 | 2020-2025 | Epioxa |
| Johnson & Johnson Surgical Vision, INC. | $80.99 | 2019-2021 | |
| Rxsight INC | $53.35 | 2025 | Light Adjustable Lens (Lal), Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd) |
| Abbvie INC. | $36.46 | 2022-2024 | |
| Ani Pharmaceuticals, INC. | $32.74 | 2025 | Purified Cortrophin Gel |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $32.04 | 2021-2024 | |
| Carl Zeiss Meditec USA, INC. | $26.41 | 2022 | |
| Allergan, INC. | $18.17 | 2021 | |
| Oyster Point Pharma, INC. | $17.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandhya Iyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.